Improving delivery of secondary prophylaxis for rheumatic heart disease

Not Applicable

Completed

• Conditions: Rheumatic Heart Disease; Acute Rheumatic Fever; Cardiovascular - Other cardiovascular diseases; Public Health - Health service research

• Registration Number: ACTRN12613000223730
• Lead Sponsor: niversity of Western Australia

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-02-25
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

Health centres in the Northern Territory with at least 10 clients on secondary prophylaxis

Exclusion Criteria

Health centres outside the Northern Territory
Health centres with less than 10 clients on secondary prophylaxis

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The proportion of clients receiving 80% or more of scheduled benzathine penicillin G (BPG) injections over a minimum 12 month period. Monthly adherence data are routinely reported by health centre staff and data are stored by the RHD register. The project will use the NT RHD register data for this outcome.[The primary outcome will be measured on a monthly basis for the 15 months of the intervention. Due to a potential delay in intervention effect, the average adherence for months 3 -15 will be used to compare with the baseline period. ]